Back to UBS Group AG UBS Group AG

CPHICPHI
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in CHINA PHARMA HLDGS INC

UBS Group AG holds 3,109 shares of CPHI (CHINA PHARMA HLDGS INC), worth $2,052 as of 2026-Q2. The position was increased (+699.2% shares).

Current Value

$2,052

Current Shares

3,109

Total Value Change

-$125,455

Total Shares Change

-68,124

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3,109
+699.2%
$2,0520.0%$0.66
12
2026-Q1
Decreased
389
-24.2%
$2370.0%$0.55
0
2025-Q4
Decreased
513
-97.3%
$6210.0%$1.33
0
2025-Q3
Decreased
19,191
-73.1%
$37,4220.0%$1.96
0
2025-Q2
New
71,233
-
$127,5070.0%$1.83
34

Other major holders of CPHI: CITADEL ADVISORS LLC, HRT FINANCIAL LP, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used